Brief: EQL Pharma Q2 EBIT Rises To SEK 3.4 Mln
06/11/2020 07:15
Nov 6 (Reuters) - EQL Pharma AB EQL.TE :
* INTERIM REPORT APRIL - SEPTEMBER 2020
* CONSOLIDATED SALES DURING Q2 AMOUNTED TO SEK 24.2 (17.9)
MILLION, AN INCREASE OF 36%
* Q2 EBIT FOR QUARTER WAS SEK 3.4 (1.2) MILLION
Source text for Eikon: ID:nWkr2Xxm9C
Further company coverage: EQL.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))